Topics

Human medicines European public assessment report (EPAR): Yargesa, miglustat, Gaucher Disease, Date of authorisation: 22/03/2017, Revision: 2, Status: Authorised

05:25 EDT 3 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Yargesa, miglustat, Gaucher Disease, Date of authorisation: 22/03/2017, Revision: 2, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Yargesa, miglustat, Gaucher Disease, Date of authorisation: 22/03/2017, Revision: 2, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Yargesa, miglustat, Gaucher Disease, Date of authorisation: 22/03/2017, Revision: 2, Status: Authorised"

Quick Search